https://pharmadispatch.com/news/island-pharmaceuticals-announces-the-appointment-of-new-chair
Island Pharmaceuticals announces the appointment of new chair - BioPharmaDispatch
Australian antiviral drug development company Island Pharmaceuticals (ASX: ILA) has announced the appointment of Jason Carroll as its non-executive chairman.
island pharmaceuticalsthe appointmentannouncesnewchair
https://informaconnect.com/asia-bio-partnering-forum/sponsors/island-pharmaceuticals-ltd/
Island Pharmaceuticals Ltd | Asia Bio Partnering Forum
Organisation profile for Island Pharmaceuticals Ltd
island pharmaceuticalsltdasiabiopartnering
https://smallcaps.com.au/article/island-pharmaceuticals-raises-dollar9m-to-fund-clinical-development-as-fda-approves-galidesivir-pathway
Island Pharmaceuticals Raises $9m to Fund Clinical Development as FDA Approves Galidesivir Pathway
Feb 4, 2026 - Island Pharmaceuticals (ASX: ILA) secures FDA Animal Rule path for galidesivir and $9m funding to fast-track two-stage trials and US govt procurement potential.
island pharmaceuticalsclinical developmentfundfdaapproves
https://www.pharmacompass.com/apis-products/island-pharmaceuticals
Island Pharmaceuticals | Active Pharmaceutical Ingredients | API | DMF | CEP | List
View All Active Pharmaceutical Ingredients (API) with Drug Master Files (DMF), CEP / COS, Japanese DMFs, Written Confirmation (WC) manufactured or supplied by...
island pharmaceuticalsactiveingredientsapidmf
https://mtec-sc.org/members/island-pharmaceuticals-ltd
Island Pharmaceuticals Limited | MTEC
Island Pharmaceuticals develops repurposed small molecule antivirals for mosquito-borne diseases like dengue and Zika.
island pharmaceuticalslimited